Dako north america, INC:1110278 [16-040444]

Ended Purchase Order Awarded Last action

Contract number
HHSN261201600353P
Awardee
Awarding agency
Obligated
$3,556

Award facts

Contract value 100% obligated
$3,556.11 Current and potential, with all options
Completion date 100% complete
Current and potential, with all options
Set-aside
No set-aside
Competition
Not Competed under SAP · 1 offer Simplified Acquisition
Pricing
Firm Fixed Price
Place of performance
Bethesda, MD 20892, USA

Award details come from SAM.gov/FPDS.

Transactions

Action Obligated Date
Funding Only Action P00001 · Service contract dako north america, INC:1110278 [16-040444] -$1,444
Original award $5,000

About this award

The National Cancer Institute issued a purchase order to Dako North America, Inc. for $3,556.11 on May 23, 2016, with completion by May 31, 2017. Performance occurs at Bethesda, Maryland. The order is firm fixed price with no set-aside. Dako North America is a subsidiary of Agilent Technologies, Inc.

Quick answers

Who was awarded contract HHSN261201600353P?

HHSN261201600353P was awarded to Dako North America, Inc. by National Cancer Institute (National Institutes of Health) on May 23, 2016.

How much is contract HHSN261201600353P worth?

The government has obligated $3,556 on HHSN261201600353P.

Was contract HHSN261201600353P competed?

The extent of competition for HHSN261201600353P was not competed under sap. The government received 1 offer.

On GovTribe

See this award's full record

  • Every transaction and funding action
  • The awardee's other awards and teaming partners
  • Similar awards and recompete opportunities
  • Ask GovTribe AI about this award